Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
US Patent 11285140 Piperidin-4-yl azetidine derivatives as JAK1 inhibitors
Overview
Structured Data
Issues
Contributors
Activity
All edits
Edits on 28 Aug, 2024
"update inverses"
Golden AI
edited on 28 Aug, 2024
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent Citations Received
US Patent 12071439 Process and intermediates for preparing a JAK inhibitor
0
Edits on 29 May, 2024
"update inverses"
Golden AI
edited on 29 May, 2024
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent Citations Received
US Patent 11992490 Use of JAK1 inhibitors for the treatment of cutaneous lupus erythematosus and Lichen planus (LP)
0
Edits on 22 Feb, 2024
"update inverses"
Golden AI
edited on 22 Feb, 2024
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent Citations Received
US Patent 11905292 Process and intermediates for preparing a JAK inhibitor
0
Edits on 7 Dec, 2023
"update inverses"
Golden AI
edited on 7 Dec, 2023
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent Citations Received
US Patent 11833155 Combination therapy for treatment of myeloproliferative neoplasms
0
Edits on 16 Oct, 2023
"Add patent inventor(s)"
Golden AI
edited on 16 Oct, 2023
Edits made to:
Infobox
(
+2
properties)
Infobox
Patent Inventor Names
Chu-Biao Xue
0
Taisheng Huang
0
Edits on 7 Sep, 2023
"update inverses"
Golden AI
edited on 7 Sep, 2023
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent Citations Received
US Patent 11744832 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors
Edits on 22 Jul, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI
edited on 22 Jul, 2023
Edits made to:
Infobox
(
-1
properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=11285140
Edits on 24 Apr, 2023
"update citations for inverse infoboxes"
Golden AI
edited on 24 Apr, 2023
Infobox
Patent Citations
US Patent 10166191 Sustained-release dosage forms of ruxolitinib
0
Edits on 7 Apr, 2023
"update citations for inverse infoboxes"
Golden AI
edited on 7 Apr, 2023
Infobox
Patent Citations
US Patent 10398699 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors
0
Edits on 28 Mar, 2023
"update citations for inverse infoboxes"
Golden AI
edited on 28 Mar, 2023
Infobox
Patent Citations
US Patent 11045421 Sustained release dosage forms for a JAK1 inhibitor
0
"update citations for inverse infoboxes"
Golden AI
edited on 28 Mar, 2023
Infobox
Patent Citations Received
US Patent 11576864 Sustained-release dosage forms of ruxolitinib
0
Edits on 28 Mar, 2023
"update citations for inverse infoboxes"
Golden AI
edited on 28 Mar, 2023
Infobox
Patent Citations
US Patent 10639310 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors
0
"update citations for inverse infoboxes"
Golden AI
edited on 27 Mar, 2023
Infobox
Patent Citations
US Patent 10766900 Baricitinib intermediate, method for forming Baricitinib intermediate, and method for preparing Baricitinib or pharmaceutically acceptable salt thereof
0
"update citations for inverse infoboxes"
Golden AI
edited on 27 Mar, 2023
Infobox
Patent Citations
US Patent 10561616 Sustained release dosage forms for a JAK1 inhibitor
0
Edits on 26 Mar, 2023
"update citations for inverse infoboxes"
Golden AI
edited on 26 Mar, 2023
Infobox
Patent Citations Received
US Patent 11337927 Sustained-release dosage forms of ruxolitinib
0
Edits on 22 Mar, 2023
"update citations for inverse infoboxes"
Golden AI
edited on 22 Mar, 2023
Infobox
Patent Citations Received
US Patent 11576865 Sustained-release dosage forms of ruxolitinib
0
"update citations for inverse infoboxes"
Golden AI
edited on 22 Mar, 2023
Infobox
Patent Citations
US Patent 10874616 Sustained-release dosage forms of ruxolitinib
0
Edits on 15 Feb, 2023
"update inverses"
Golden AI
edited on 15 Feb, 2023
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent Citations Received
US Patent 11576865 Sustained-release dosage forms of ruxolitinib
0
"update inverses"
Golden AI
edited on 15 Feb, 2023
Edits made to:
Infobox
(
+1
properties)
Infobox
Patent Citations Received
US Patent 11576864 Sustained-release dosage forms of ruxolitinib
0
Edits on 26 Sep, 2022
"update citations for inverse infoboxes"
Golden AI
edited on 26 Sep, 2022
Infobox
Patent Citations
US Patent 11045421 Sustained release dosage forms for a JAK1 inhibitor
0
Load more
Find more entities like US Patent 11285140 Piperidin-4-yl azetidine derivatives as JAK1 inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
By using this site, you agree to our
Terms of Service
.
SUBSCRIBE